Seres Therapeutics, Inc.

Cambridge, MA

UEI
X7LRVD7ZXMK5
CAGE
7V3D4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
101 Cambridgepark Dr, Cambridge, MA 02140, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
Trustees Of Boston University CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA Seres is developing a novel Live Biotherapeutic Product (LBP) of human commensal bacteria formulated for oral liquid… 75A50122C00028 $895,707

Quick answers

Is Seres Therapeutics, Inc. registered in SAM.gov?

Yes. Seres Therapeutics, Inc.'s SAM.gov registration is active through April 22, 2027.

On GovTribe

See Seres Therapeutics, Inc.'s full federal record

  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login